DoD Peer Reviewed Orthopaedic Clinical Trial Development Award

The summary for the DoD Peer Reviewed Orthopaedic Clinical Trial Development Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Peer Reviewed Orthopaedic Clinical Trial Development Award: The PRORP Clinical Trial Development Award (CTDA) is intended to support the planning and development activities necessary to support preparation for clinical trials with the potential to have a significant impact on military combat-related orthopaedic injuries. The clinical trials proposed may be focused on any aspect of treatment of combat-related orthopaedic injuries that addresses the FY13 PRORP CTDA Focus Areas outlined below, including the evaluation of promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. All applications are required to justify the relevance of the proposed project to military and/or Veteran populations affected by combat-related orthopaedic injury. Collaboration with military researchers and clinicians is encouraged, and studies that plan to include active duty military or Veteran participants as all or a portion of the study population will be given higher priority for funding during programmatic review.